Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Gastroenterology. 2022 Jul 16;163(5):1252–1266.e2. doi: 10.1053/j.gastro.2022.06.090

Figure 1.

Figure 1.

Expression level of identified cell-free and exosomal miRNA candidates for the diagnosis of patients with early-stages of PDAC obtained from genome-wide small RNA sequencing. (A) Expression level of candidate cf-miRNAs and representative heatmap in patients with early-stage of PDAC (Stage I-II) versus non-disease control samples. (B) Expression level of candidate exo-miRNAs and representative heatmap in patients with PDAC (Stage I-II) versus non-disease control samples. The miRNA expression profile was z-normalized. [miRNA: micro RNA; CPM: counts per million; FC: fold change; PDAC: pancreatic ductal adenocarcinoma (light blue) and Non-disease controls (dark blue)].